Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/Naloxone Prolonged-Release vs Oxycodone Prolonged-Release in Cancer Pain
CTR20192045Phase 3Completed
- Sponsor
- Napp Pharmaceuticals
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone + naloxone in cancer pain, sponsored by Napp Pharmaceuticals. Started Dec 2019; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
cancer pain
Beyond the preview
Go deeper on CTR20192045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192045.